<DOC>
	<DOCNO>NCT01271998</DOCNO>
	<brief_summary>The primary purpose study determine steady-state plasma pharmacokinetics ( PK ) property TR-700 pulmonary epithelial lining fluid ( ELF ) alveolar macrophage ( AM ) healthy volunteer .</brief_summary>
	<brief_title>Pulmonary Disposition TR-700 Following Once-Daily Oral 200 mg</brief_title>
	<detailed_description>No applicable .</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Torezolid phosphate</mesh_term>
	<criteria>Healthy male female , 18 55 year age , inclusive Females must nonpregnant , nonlactating , either postmenopausal surgically sterile practice effective method birth control Males must surgically sterile , abstinent , practice effective method birth control BMI 20 34.9 kg/m2 , inclusive Allergy lidocaine , midazolam , anesthetics/sedatives similar class Physiciandiagnosed migraine headache within 3 year Previous enrollment TR701 TR701 FA trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>antibiotic</keyword>
	<keyword>healthy subject</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>